PET/CT bests biopsy in diagnosing lymphoma bone marrow involvement

05/17/2013 | MolecularImaging.net

A study published in The Journal of Nuclear Medicine said 18F-FDG-PET/CT is better than the standard bone marrow biopsy in detecting bone marrow involvement in diffuse large B-cell lymphoma. PET/CT identified bone marrow involvement in 32 patients, while biopsy detected bone malignancy in eight patients. PET/CT also showed better performance in terms of sensitivity, predictive value and negative predictive value.

View Full Article in:

MolecularImaging.net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC